Home » Topics » Regulatory

Regulatory
RSS

New nondrug treatment approved for rheumatoid arthritis in Canada

March 10, 2000

New formulation of Agouron's Viracept approved in U.S.

March 10, 2000

Pharmacia & Upjohn submits applications for once-daily Detrol formulation

March 10, 2000

AMBI to receive patent for use of calcium taurate with antihypertensive agents

March 10, 2000

The FDA approves once-daily Singulair tablet for treatment of asthma in young children

March 9, 2000

Solid oral formulations of eprosartan with enhanced bioavailability

March 9, 2000

Use of secretin for autism receives broad patent coverage

March 7, 2000

European mutual recognition approval obtained for candesartan/HCTZ combination

March 7, 2000

Noven successfully completes phase II study of MethyPatch for treatment of ADHD

March 3, 2000

Novantrone moves one step closer to approval for MS

March 3, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...